Interleukin-12 Mouse Recombinant produced in HEK 293 cells is a glycosylated disulfide linked heterodimeric polypeptide containing 506 amino acids and having a molecular weight of 75 kDa comprised of disulfide-bonded 35 kDa (p35) and 40 kDa (p40) subunits.
The IL-12 is purified by proprietary chromatographic techniques.
Mouse recombinant IL-12 is a heterodimer consisting of two subunits: p35 and p40. The p40 subunit is a 40 kDa protein, while the p35 subunit is a 35 kDa protein. Together, they form the active IL-12p70 heterodimer, which has a total molecular mass of approximately 70 kDa . The recombinant form of IL-12 is produced using various expression systems, such as HEK293 cells, to ensure high purity and biological activity .
IL-12 is a key cytokine in the immune response, with several important functions:
Recombinant mouse IL-12 is widely used in immunological research to study its effects on various immune cells and to investigate its potential therapeutic applications. Some common applications include:
IL-12 has shown promise as a therapeutic agent due to its ability to enhance immune responses. It has been investigated in various clinical trials for its potential use in treating cancer, infectious diseases, and autoimmune disorders. However, its clinical application is limited by its potential side effects, such as systemic inflammation and toxicity .
In conclusion, Interleukin-12 (Mouse Recombinant) is a vital cytokine with significant roles in the immune system. Its recombinant form is a valuable tool in immunological research, providing insights into its functions and potential therapeutic applications.